Cytosorbents Corporation

The momentum for this stock is not very good. Cytosorbents Corporation is a mediocre stock to choose.
Log in to see more information.
CytoSorbents Corp. engages in the research and development of blood purification technology for the...

News

StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)
StockNews.com Initiates Coverage on Cytosorbents (NASDAQ:CTSO)

Ticker Report StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO - Get Free Report) in a report issued on Saturday. The brokerage set a "hold" rating on the medical research company's stock. A...\n more…

Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com
Cytosorbents (NASDAQ:CTSO) Research Coverage Started at StockNews.com

Ticker Report StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO - Free Report) in a report issued on Friday. The brokerage issued a hold rating on the medical research company's stock. A number...\n more…

Cytosorbents (NASDAQ:CTSO) Shares Cross Above 200-Day Moving Average of $0.94
Cytosorbents (NASDAQ:CTSO) Shares Cross Above 200-Day Moving Average of $0.94

Ticker Report Shares of Cytosorbents Co. (NASDAQ:CTSO - Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.94 and...\n more…

CytoSorbents to Present at the H.C. Wainwright 26  Annual Global Investment Conference
CytoSorbents to Present at the H.C. Wainwright 26 Annual Global Investment Conference

Globe Newswire PRINCETON, N.J., Aug. 27, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in...\n more…

Cytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.com
Cytosorbents (NASDAQ:CTSO) Receives New Coverage from Analysts at StockNews.com

Ticker Report Equities researchers at StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO - Get Free Report) in a note issued to investors on Thursday. The brokerage set a "hold" rating on the...\n more…

B. Riley Comments on Cytosorbents Co.'s Q3 2024 Earnings (NASDAQ:CTSO)
B. Riley Comments on Cytosorbents Co.'s Q3 2024 Earnings (NASDAQ:CTSO)

Zolmax Cytosorbents Co. (NASDAQ:CTSO - Free Report) - Research analysts at B. Riley decreased their Q3 2024 earnings estimates for shares of Cytosorbents in a research report issued on Wednesday, August...\n more…